€2.55
0.66% today
L&S, Jul 02, 09:04 pm CET
ISIN
KYG5074A1004
Symbol
6618
Index

JD Health International Target price 2024 - Analyst rating & recommendation

JD Health International Classifications & Recommendation:

Buy
71%
Hold
21%
Sell
7%

JD Health International Target price

Target price HKD40.31
Course HKD20.95
Price potential
Number of estimates 13
13 Analysts have issued a price target JD Health International 2025 . The average JD Health International target price is HKD40.31. This is higher than the current share price. The highest price target is
HKD50.40 140.57%
register free of charge
, the lowest is .
A rating was issued by 14 analysts: 10 Analysts recommend JD Health International to buy, 3 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the JD Health International share has an average upside potential 2025 of . Most analysts recommend the JD Health International share at Purchase.

Sales and margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Forecast
Turnover Billion HKD 59.15 66.57
8.84% 12.55%
EBITDA margin 1.60% 2.70%
16,955.58% 68.39%
Net margin 4.10% 4.10%
398.79% 0.08%

14 Analysts have issued a sales forecast JD Health International 2024 . The average JD Health International sales estimate is

HKD66.6b
Unlock
. This is
12.45% higher
Unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
HKD68.0b 14.83%
Unlock
, the lowest is
HKD62.2b 5.03%
Unlock
.

This results in the following potential growth figures:

Sales forecast

2023 HKD59.2b 8.84%
2024
HKD66.6b 12.55%
Unlock
2025
HKD77.8b 16.85%
Unlock
2026
HKD89.3b 14.78%
Unlock

8 Analysts have issued an JD Health International EBITDA forecast 2024. The average JD Health International EBITDA estimate is

HKD1.8b
Unlock
. This is
83.64% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
HKD2.0b 106.57%
Unlock
, the lowest is
HKD1.5b 50.76%
Unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 HKD948m 18,444.87%
2024
HKD1.8b 89.22%
Unlock
2025
HKD2.7b 52.26%
Unlock
2026
HKD3.6b 33.22%
Unlock

EBITDA margin

2023 1.60% 16,955.58%
2024
2.70% 68.39%
Unlock
2025
3.51% 30.00%
Unlock
2026
4.08% 16.24%
Unlock

8 JD Health International Analysts have issued a net profit forecast 2024. The average JD Health International net profit estimate is

HKD2.7b
Unlock
. This is
12.69% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HKD3.1b 28.64%
Unlock
, the lowest is
HKD2.3b 5.22%
Unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 HKD2.4b 442.86%
2024
HKD2.7b 12.69%
Unlock
2025
HKD3.7b 33.72%
Unlock
2026
HKD4.5b 24.05%
Unlock

Net margin

2023 4.10% 398.79%
2024
4.10% 0.08%
Unlock
2025
4.69% 14.39%
Unlock
2026
5.07% 8.10%
Unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Forecast
Earnings per share HKD 0.76 0.86
442.86% 13.16%
P/E ratio 24.81
EV/Sales 0.34

8 Analysts have issued a JD Health International forecast for earnings per share. The average JD Health International <a href=/blog/eps>EPS is

HKD0.86
Unlock
. This is
13.16% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
HKD0.98 28.95%
Unlock
, the lowest is
HKD0.72 5.26%
Unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 HKD0.76 442.86%
2024
HKD0.86 13.16%
Unlock
2025
HKD1.15 33.72%
Unlock
2026
HKD1.42 23.48%
Unlock

P/E ratio

Current 27.87 91.60%
2024
24.81 10.98%
Unlock
2025
18.56 25.19%
Unlock
2026
14.96 19.40%
Unlock

Based on analysts' sales estimates for 2024, the JD Health International share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 0.38 77.91%
2024
0.34 10.53%
Unlock
2025
0.29 14.44%
Unlock
2026
0.25 12.86%
Unlock

P/S ratio

Current 1.14 56.02%
2024
1.02 11.07%
Unlock
2025
0.87 14.42%
Unlock
2026
0.76 12.89%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today